Shockwave Medical Inc at Morgan Stanley Global Healthcare Conference Transcript
Okay. Well, thank you, Patrick Wood on the U.S. Med Tech team. Of course, we got Doug Godshall here as well, CEO of Shockwave. So it's great to have everybody here. I'll get some fun disclosures that I have to read. So for disclosures, go to morganstanley.com/researchdisclosures. And if you have any questions, please reach out to Morgan Stanley sales rep. So that was good for.
Questions & Answers
Thanks so much for joining and agreeing to do this, Doug. I know you're a busy guy. Maybe why don't we start on like the coronary side of things? And probably big picture over the last few years, IVL uptakes has probably been faster than at least the market's expected. If we're looking forward, like is there anything you can see that would slow down that pace of adoption should we think about growth for the next couple of years moderating heavily, or is there like continued penetration behind the business and coronary?
Yes.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |